1. Home
  2. Pharma & Healthcare
  3. Global Cancer Immunotherapy Market, By Cancer Type (Breast Cancer, Melanoma, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Head & Neck, Pancreatic Cancer), By Product Type, (Immunomodulators, Other), Estimation & Forecast, 2019 - 2026

Global Cancer Immunotherapy Market, By Cancer Type (Breast Cancer, Melanoma, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Head & Neck, Pancreatic Cancer), By Product Type, (Immunomodulators, Other), Estimation & Forecast, 2019 - 2026

Publication Month: Jun 2020 | No. of Pages: 139 Published By: Esticast Research & Consulting
Single User License: US $ 4700
Corporate User License: US $ 5600

Esticast Research and Consulting offers the latest published report on Global Cancer Immunotherapy Market Analysis and Forecast from 2019 to 2026 delivering key insights and providing a competitive advantage to clients through a detailed report. Additionally, the report focuses on Cancer Immunotherapy industry key players, to define and analyze the sales volume, value, market share, market competitive landscape, and recent developments.

The Global Cancer Immunotherapy Market held a market size of USD 59.2 billion in the year 2019 and is projected to register a CAGR of 12.2% over the period 2019 to 2026.

About Global Cancer Immunotherapy Market

Firstly, the report offers a basic overview of the industry including, definitions, classifications, applications, and industry chain scenario. The Cancer Immunotherapy industry analysis is provided for the global market including development history, segment analysis, major regional developments, and a thorough competitor's evaluation.

Secondly, growth policies and plans are reviewed as well as manufacturing processes and cost structures. This report also discusses supply and consumption figures, import/export data, cost, price, revenue and gross margins by prime regions such as the U.S. Europe, China, and Japan along with other key regions. Moreover, Global Cancer Immunotherapy Market proposes market trend analysis, drivers, and challenges by consumer behavior, and various marketing channels.

Competitive Glimpse

Top listed manufacturers for Global Global Cancer Immunotherapy Market are:

Amgen Inc.
Bayer AG
Bristol-Myers Squibb
AstraZeneca
F. Hoffman La Roche
Eli Lilly and Co.
Johnson & Johnson
Novartis
Merck and Co.
Pfizer

With the slowdown in world economic growth, the Cancer Immunotherapy industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years.

How has the competitive landscape of this industry been categorized?

The competitive scope of Global Cancer Immunotherapy Market spans firms listed above, as per the report.
The report includes substantial information pertaining to the produced goods, company profile, revenue graph, as well as other production patterns.
The research study also presents details with respect to the market share that every company accounts for, as well as gross margins and price prototypes of the products.

Market Segmentation:

Esticast Research offers a crystal clear view of the various sections such as segmental analysis, regional analyst, product portfolios, followed by detailed information about market leaders and their strategies about mergers and acquisitions.

Cancer Immunotherapy Market Key Segments:
By Cancer Type

Breast Cancer
Melanoma
Lung Cancer
Colorectal cancer
Prostate Cancer
Ovarian cancer
Head & Neck
Pancreatic Cancer
By Product Type

Immunomodulators
Monoclonal Antibodies
Oncolytic Viral Therapies & Cancer Vaccines

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

North America
Europe
Asia-Pacific
South America
The Middle East and Africa

Reasons to access this report:

Esticast Research and Consulting report is designed in a method that assists clients to gain a complete knowledge of the complete market scenario and the important sectors.
This report consists of meticulous overview of market dynamics, and thorough research.
Explore further market prospects and identify high potential categories based on comprehensive volume and value analysis
Detail information on competitive landscape, current market trends and evolving technologies that can be useful for the companies which are competing in this market
Gaining knowledge about competitive landscape based on thorough brand share analysis to plan an active market positioning

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Global Cancer Immunotherapy Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.4. Restraints
3.5. Opportunities
3.6. Porter's Five Forces Analysis
3.6.1. Bargaining Power of Supplier
3.6.2. Bargaining Power of Buyer
3.6.3. Threat of Substitute
3.6.4. Threat of New Entrants
3.6.5. Competitive Rivalry
3.7 PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Economic Landscape
3.7.3. Technological Landscape
3.7.4. Environmental Landscape
3.7.5. Social Landscape
3.8. Market Share Analysis

4. Global Cancer Immunotherapy Market, By Cancer Type
4.1. Overview
4.2. Breast Cancer
4.2.1. Market Size & Forecast, 2019-2026
4.3. Melanoma
4.3.1. Market Size & Forecast, 2019-2026
4.4. Lung Cancer
4.4.1. Market Size & Forecast, 2019-2026
4.5. Colorectal Cancer
4.5.1. Market Size & Forecast, 2019-2026
4.6. Prostate Cancer
4.6.1. Market Size & Forecast, 2019-2026
4.7. Ovarian Cancer
4.7.1. Market Size & Forecast, 2019-2026
4.8. Head & Neck
4.8.1. Market Size & Forecast, 2019-2026
4.9. Pancreatic Cancer
4.9.1. Market Size & Forecast, 2019-2026

5. Global Cancer Immunotherapy Market, By Product Type
5.1. Overview
5.2. Immunomodulators
5.2.1. Market Size & Forecast, 2019-2026
5.3. Monoclonal Antibodies
5.3.1 Market Size & Forecast, 2019-2026
5.4. Oncolytic viral Therapies & Cancer Vaccines
5.4.1 Market Size & Forecast, 2019-2026

6. Global Cancer Immunotherapy Market, Region
6.1. Overview
6.1.1. Global Market Size & Forecast, 2019-2026
6.2. North America Cancer Immunotherapy Market
6.2.1. North America Market Size & Forecast, 2019-2026, By Country
6.2.2. North America Market Size & Forecast, 2019-2026, By Cancer Type
6.2.3. North America Market Size & Forecast, 2019-2026, By Product Type
6.2.4. U.S.
6.2.4.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.2.4.2. Market Size and Forecast, 2019-2026, By Product Type
6.2.5. Canada
6.2.5.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.2.5.2. Market Size and Forecast, 2019-2026, By Product Type
6.3. Europe Cancer Immunotherapy Market
6.3.1. Europe Market Size & Forecast, 2019-2026, By Country
6.3.2. Europe Market Size & Forecast, 2019-2026, By Cancer Type
6.3.3. Europe Market Size & Forecast, 2019-2026, By Product Type
6.3.4. Germany
6.3.4.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.4.2. Market Size and Forecast, 2019-2026, By Product Type
6.3.5. France
6.3.5.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.5.2. Market Size and Forecast, 2019-2026, By Product Type
6.3.6. UK
6.3.6.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.6.2. Market Size and Forecast, 2019-2026, By Product Type
6.3.7. Italy
6.3.7.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.7.2. Market Size and Forecast, 2019-2026, By Product Type
6.3.8. Spain
6.3.8.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.8.2. Market Size and Forecast, 2019-2026, By Product Type
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.3.9.2. Market Size and Forecast, 2019-2026, By Product Type
6.4. Asia-Pacific Cancer Immunotherapy Market
6.4.1. Asia-Pacific Market Size & Forecast, 2019-2026, By Country
6.4.2. Asia-Pacific Market Size & Forecast, 2019-2026, By Cancer Type
6.4.3. Asia-Pacific Market Size & Forecast, 2019-2026, By Product Type
6.4.4. Japan
6.4.4.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.4.2. Market Size and Forecast, 2019-2026, By Product Type
6.4.5. China
6.4.5.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.5.2. Market Size and Forecast, 2019-2026, By Product Type
6.4.6. Australia
6.4.6.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.6.2. Market Size and Forecast, 2019-2026, By Product Type
6.4.7. India
6.4.7.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.7.2. Market Size and Forecast, 2019-2026, By Product Type
6.4.8. South Korea
6.4.8.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.8.2. Market Size and Forecast, 2019-2026, By Product Type
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.4.9.2. Market Size and Forecast, 2019-2026, By Product Type
6.5. South America Cancer Immunotherapy Market
6.5.1. South America Market Size & Forecast, 2019-2026, By Country
6.5.2. South America Market Size & Forecast, 2019-2026, By Cancer Type
6.5.3. South America Market Size & Forecast, 2019-2026, By Product Type
6.5.4. Brazil
6.5.4.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.5.4.2. Market Size and Forecast, 2019-2026, By Product Type
6.5.5. Argentina
6.5.5.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.5.5.2. Market Size and Forecast, 2019-2026, By Product Type
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.5.6.2. Market Size and Forecast, 2019-2026, By Product Type
6.6. Middle East & Africa Cancer Immunotherapy Market
6.6.1. Middle East & Africa Market Size & Forecast, 2019-2026, By Country
6.6.2. Middle East & Africa Market Size & Forecast, 2019-2026, By Cancer Type
6.6.3. Middle East & Africa Market Size & Forecast, 2019-2026, By Product Type
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.6.4.2. Market Size and Forecast, 2019-2026, By Product Type
6.6.5. Egypt
6.6.5.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.6.5.2. Market Size and Forecast, 2019-2026, By Product Type
6.6.6. South Africa
6.6.6.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.6.6.2. Market Size and Forecast, 2019-2026, By Product Type
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast, 2019-2026, By Cancer Type
6.6.7.2. Market Size and Forecast, 2019-2026, By Product Type

9. Company Profile
9.1. Bayer AG
9.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
9.1.2. Product Information, and Specification
9.1.3. Financial Performance
9.1.4. Strategic Initiatives
9.2. Bristol-Myers Squibb
9.3. AstraZeneca
9.4. Amgen Inc.
9.5. F. Hoffman La Roche
9.6 Johnson & Johnson
9.7 Novartis
9.8 Merck and Co.
9.9 Eli Lilly and Co.
9.10 Pfizer
10. List of Tables
Table 1 Global Cancer Immunotherapy Market Share, By Cancer Type, 2016-2026 ($Billion)
Table 2 Global Cancer Immunotherapy Market Share, By Product Type, 2016-2026 ($Billion)
Table 3 Global Cancer Immunotherapy Market Value, 2016-2026 ($Billion)
Table 4 North America, Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion)
Table 5 North America, Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion)
Table 6 North America Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 7 North America Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion)
Table 8 U.S. Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 9 U.S. Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion)
Table 10 Canada Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 11 Canada Cancer Immunotherapy Market Share Value, By Product Type 2016-2026 ($Billion)
Table 12 Europe Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion)
Table 13 Europe Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion)
Table 14 Europe Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 15 Europe Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 16 UK Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 17 UK Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 18 Germany Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 19 Germany Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 20 France Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 21 France Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 22 Italy Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 23 Italy Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 24 Rest of Europe Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 25 Rest of Europe Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 26 Asia Pacific Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion)
Table 27 Asia Pacific Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion)
Table 28 Asia Pacific Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 29 Asia Pacific Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 30 India Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 31 India Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 32 China Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 33 China Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 34 Japan Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 35 Japan Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 36 South Korea Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 37 South Korea Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 38 Rest of Asia Pacific Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 39 Rest of Asia Pacific Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 40 South America Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion)
Table 41 South America Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion)
Table 42 South America Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 43 South America Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 44 Brazil Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 45 Brazil Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 46 Argentina Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 47 Argentina Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 48 Mexico Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 49 Mexico Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 50 Rest of South America, Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 51 Rest of South America Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 52 Middle East & Africa Cancer Immunotherapy Market Value and Growth Rate, 2016-2026 ($Billion)
Table 53 Middle East & Africa Cancer Immunotherapy Market Share Value, By Country, 2016-2026 ($Billion)
Table 54 Middle East & Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 55 Middle East & Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 56 GCC Countries Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 57 GCC Countries Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 58 Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 59 Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 60 Rest of Middle East & Africa Cancer Immunotherapy Market Share Value, By Cancer Type, 2016-2026 ($Billion)
Table 61 Rest of Middle East & Africa Cancer Immunotherapy Market Share Value, By Product Type, 2016-2026 ($Billion)
Table 62 Recent Developments

10. List of Figures
Figure 1 Global Cancer Immunotherapy Market Overview
Figure 2 Global Cancer Immunotherapy Market Segmentation
Figure 3 Global Cancer Immunotherapy Market Drivers
Figure 4 Global Cancer Immunotherapy Market Restraints
Figure 5 Global Cancer Immunotherapy Market Porter's Analysis
Figure 6 Global Cancer Immunotherapy Market share, By Cancer Type, 2018 VS 2026 (%)
Figure 7 Global Cancer Immunotherapy Market share, By Product Type, 2018 VS 2026 (%)
Figure 8 U.S. Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 9 Canada Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 10 U.K. Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 11 Germany Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 12 France Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 13 Italy Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 14 Rest of Europe Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 15 India Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 16 China Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 17 Japan Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 18 South Korea Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 19 Rest of Asia Pacific Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 20 Brazil Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 21 Argentina Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 22 Rest of South America Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 23 GCC Countries Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 24 Africa Cancer Immunotherapy Market share, 2016-2026 ($Billion)
Figure 25 Rest of Middle East & Africa Cancer Immunotherapy Market share, 2016-2026 ($Billion)

Tables and Figures



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets